Additional fibrate treatment in UDCA-refractory PBC patients.
Sung Won ChungJeong-Hoon LeeMinseok Albert KimGalam LeemSun Woong KimYoung ChangHyo Young LeeJun Sik YoonJun Yong ParkYun Bin LeeEun-Ju ChoSu Jong YuYoon Jun KimJung-Hwan YoonPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
In patients with UDCA-refractory PBC, additional fibrate treatment is associated with a higher probability of ALP normalization and a lower risk of cirrhosis development and hepatic deterioration.